| Catalog Number | KRP419 | 
																		| Alias | 自旋素, Autotaxin , EC 3.1.4.39, EC 3.1.4.4, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, E-NPP 2, Extracellular lysophospholipase D, LysoPLD, ATX, PDNP2, Autotaxin | 
																		| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
																		| Product Description | Human ENPP2(49-863 aa) | 
																		| Molecular Name | ENPP2 | 
																		| Product Introduction | 自旋素调节细胞外磷脂代谢,影响细胞迁移和增殖。。 | 
																		| Molecular Weight | 99&103 kDa | 
																		| Expression System | HEK293F Cells | 
																		| Species | Human | 
																		| Concentration | 联系销售经理获得最新批次的浓度 | 
																		| Purity | ≥90% | 
																		| SDS-PAGE |   | 
																		| Purification | Affinity Purification | 
																		| Uniprot ID | Q13822 | 
																		| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
																		| Formulation | Supplied in PBS | 
																		| Shipping Condition | This product is shipped on ice packs or dry ice. | 
																		| Background | Secreted lysophospholipase D that hydrolyzes lysophospholipids to produce the signaling molecule lysophosphatidic acid (LPA) in extracellular fluids (PubMed:12354767, PubMed:14500380, PubMed:15769751, PubMed:26371182, PubMed:27754931). Its major substrate is lysophosphatidylcholine (PubMed:12176993, PubMed:14500380, PubMed:27754931). Can also act on sphingosylphosphorylcholine producing sphingosine-1-phosphate, a modulator of cell motility (PubMed:14500380). Can hydrolyze, in vitro, bis-pNPP, to some extent pNP-TMP, and barely ATP (PubMed:12176993, PubMed:15769751). Involved in several motility-related processes such as angiogenesis and neurite outgrowth. Acts as an angiogenic factor by stimulating migration of smooth muscle cells and microtubule formation (PubMed:11559573). Stimulates migration of melanoma cells, probably via a pertussis toxin-sensitive G protein (PubMed:1733949). May have a role in induction of parturition (PubMed:12176993). Possible involvement in cell proliferation and adipose tissue development (Probable). Required for LPA production in activated platelets, cleaves the sn-1 lysophospholipids to generate sn-1 lysophosphatidic acids containing predominantly 18:2 and 20:4 fatty acids (PubMed:21393252). Shows a preference for the sn-1 to the sn-2 isomer of 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) (PubMed:21393252). {ECO:0000269|PubMed:11559573, ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:12354767, ECO:0000269|PubMed:14500380, ECO:0000269|PubMed:15769751, ECO:0000269|PubMed:1733949, ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:21393252, ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000305|PubMed:15700135}. | 
																		| Endotoxin | < 0.1 EU per ug | 
																		| Biological Activity |  Measured by its ability to cleave Bis (pNitrophenyl) Phosphate (BPNPP). The specific activity is >8,000 pmol/min/μg, as measured under the described conditions. | 
																		| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 |